We present four patients in whom a "ketofol" (ketamine 200 mg and propofol 200 mg) 
Ketamine is a dissociative anaesthetic with significant analgesic properties, which was first introduced into clinical practice in 1964. It is still widely used as an anaesthetic in the third world, in disaster situations and in out-of-hospital emergencies. It has advantages in these settings, as it does not usually impair airway maintenance or spontaneous respiration. It has experienced a resurgence in use over the last decade in acute and chronic pain settings 1 . Propofol was first introduced into clinical practice in the 1980s as an induction agent. Currently it is widely used as an infusion to provide anaesthesia or sedation, often in association with regional anaesthesia.
"Ketofol" is constituted as a 1:1 mixture of ketamine 200 mg and propofol 200 mg to a total volume of 22 ml. This results in propofol and ketamine concentrations of approximately 10 mg/ml each.
Ketofol has been used in bolus form to provide sedation and analgesia for painful procedures in the emergency room 2 and a propofol-ketamine infusion has also been used to provide anaesthesia for coronary artery surgery 3 . Ketamine and propofol appear to counter each other's adverse effects, conferring several advantages including haemodynamic stability.
Therefore, we speculated that ketofol infusion might be a suitable sedative and analgesic agent to use in patients considered 'high risk' because of their medical condition or age. We describe our use of ketofol infusion in conjunction with regional anaesthesia in four patients.
CASE HISTORIES

Case 1
A 67-year-old man, ASA physical status IV, was scheduled for the excision of an infected right common femoral artery Angioseal ® , with endarterectomy and vein patch, and an open washout of his right knee. He had a history of ischaemic heart disease including a previous myocardial infarction and 11 days previously he had undergone coronary angiography. This had shown severe multi-vessel disease and he was awaiting coronary artery bypass grafting.
He presented with a tender and swollen right groin and a septic right knee effusion, thought to be caused by emboli from the infected Angioseal ® . He had associated fever, rigors, nausea and vomiting. Other acute problems were mild anaemia (Hb= 96 g/l), renal impairment (Cr=132 micromol/l) and dehydration. An intravenous heparin infusion had been commenced.
Standard monitoring was instituted and a left radial arterial line was inserted. Oxygen supplementation at 6 l/min was provided by a facemask with an attached capnograph. The patient was given 1 mg midazolam and a bolus dose of 2 ml of ketofol. A ketofol infusion was commenced at 5 ml per hour and maintained between 5 and 8 ml/hour for the duration of the groin with local anaesthesia and performed a femoral nerve block under direct vision after completion of the femoral artery surgery. Three boluses of fentanyl 25 µg were administered during the case. The patient maintained good gas exchange throughout. He was haemodynamically stable and comfortable throughout the procedure and pain-free and alert in the recovery room.
Case 2
A 91-year-old woman, ASA physical status III, was scheduled for open fixation of a fractured right neck of femur. Her medical history included hypertension and dementia and she was non-communicative.
Standard monitoring was instituted and oxygen supplementation at 6 l/min was provided by a facemask with an attached capnograph. A 3 ml bolus of ketofol was administered followed by a continuous infusion at 3 ml/hour for the 90 minute procedure. A fascia iliaca compartment block was performed with 20 ml of 0.75% ropivacaine. The patient was haemodynamically stable during surgery. Oxygen saturation remained 96% and a regular respiratory pattern was noted. She showed no response to the surgical stimulus. In the recovery room she remained pain-free with stable observations and was discharged to the ward after 45 minutes.
Case 3
A 67-year-old man presented for a semi-urgent endoluminal repair of a tender 6.7 cm abdominal aortic aneurysm. He was considered not fit for a general anaesthesia because of severe emphysema. He could walk a distance of only 15 to 20 metres and had a FEV 1 of 0.9 l. Two previous intensive care unit admissions had required prolonged ventilatory support via tracheostomies. Other past medical history included ischaemic heart disease and epilepsy.
Routine monitoring was instituted and an arterial line was inserted. Oxygen supplementation at 6 l/min was provided by a facemask with an attached capnograph. Both groins were infiltrated with local anaesthesia by the surgeons. He was given 1 mg midazolam and a 2 ml bolus of ketofol. Ketofol was then infused at 6 ml/hour for the duration of the three hour procedure, which subsequently included a femoral-femoral cross-over graft. He also received four boluses of fentanyl 25 µg.
He was comfortable for the duration of the case. Arterial blood gas analyses showed moderate CO 2 retention, but otherwise stable gas exchange. He was alert and comfortable in the recovery room. He was discharged from hospital six days later.
Case 4
A 75-year-old, 133 kg woman was scheduled for a right hip hemi-arthroplasty. She had a history of chronic obstructive airways disease and inflammatory bowel disease. She refused a general anaesthetic so a spinal anaesthetic using 15 mg hyperbaric bupivacaine was performed at the L3-4 level. Standard monitoring was instituted and oxygen supplementation at 6 l/min was provided by a facemask with an attached capnograph.
She was placed in the left lateral position for surgery and was comfortable until two hours into the procedure when she began to complain of surgical pain due to a diminishing spinal block. A ketofol infusion was prepared and the patient given two 5 ml boluses followed by an infusion at 10 ml/h. Fentanyl 25 µg was given on two occasions. She maintained an arterial oxygen saturation of 98%, although her airway had to be supported intermittently because of her positioning.
She was fully alert within 15 minutes of the completion of surgery. In the recovery room she reported mild nausea and discomfort, but these responded well to conventional therapy.
DISCuSSION
These four cases demonstrate the safe and effective use of ketofol, when used by infusion in combination with regional anaesthesia, in patients where more conventional techniques were deemed too risky or undesirable.
Volatile agents depress the cardiovascular and respiratory systems while inhalational anaesthesia also has the disadvantage of usually requiring airway instrumentation. Propofol also causes cardiorespiratory depression. However, the addition of ketamine should counteract this. Similarly, other characteristics of propofol and ketamine appear to be complementary. Propofol blunts the emetogenic and psycho-cognitive effects of ketamine and ketamine adds an analgesic effect not provided by propofol 2 . Thus, the adverse effects of ketamine and propofol somewhat balance each other (Table 1) . Nevertheless, it is also possible that the lack of side-effects of ketofol in our four patients was due to the relatively low doses used.
The sedative effects of ketamine and propofol are additive, thus allowing lower total doses of each drug. The dosage of ketofol depends on the age and physical status of the patient. In three of our cases, we used an initial bolus of 2 to 3 ml followed by an infusion of between 3 and 8 ml per hour, titrated to effect. However in case 4, a larger bolus and infusion rate were used due to the patient's large body mass. Some patients also required small doses of midazolam and fentanyl.
Blood gas analysis performed during ketofol sedation generally showed good oxygenation and only occasional mild hypercarbia.
Ketamine and propofol have been shown to be pharmaceutically compatible when mixed together in the same syringe 5 . The convenient 1:1 dilution (200 mg of each) simplifies the preparation of ketofol.
The use of ketofol has been reported previously in an emergency department in boluses to provide sedation and analgesia for painful procedures. In this study, 114 patients received ketofol primarily for short orthopaedic procedures. Ketofol was effective, there were no major adverse effects, the patients recovered rapidly and staff and patients were highly satisfied 2 . Propofol 400 mg mixed with ketamine 100 mg in a 60 ml syringe has been infused as the sole anaesthetic for coronary artery bypass surgery. Compared with a fentanyl-enflurane based anaesthetic, in a study of 78 adult patients, the propofol-ketamine group had less need for inotropic agents following cardiopulmonary bypass, a shorter time to tracheal extubation and a reduced incidence of myocardial ischaemia and infarction. In this study the authors emphasised the counteraction of propofol's negative haemodynamic effects by ketamine 3 . The addition of ketamine to propofol for procedural anaesthesia in children has reduced propofol and fentanyl consumption with improved haemodynamics 6 . Ketofol infusion, or other ketamine-propofol combinations, could have a wider role in anaesthetic practice, such as when ketamine or propofol are currently used independently. For example, ketamine is widely used in the third world, in retrieval medicine and in disaster areas. It was found to be the most useful anaesthetic agent by a medical team in Banda Aceh, Indonesia, after the Boxing Day Tsunami in 2004. Spontaneous ventilation under intravenous ketamine anaesthesia was used for 117 procedures. Although generally well tolerated, occasional ketamine-related side-effects included vocalisation, grimacing, limb movements, bad dreams, excessive salivation and postoperative nausea and vomiting 7 . These adverse effects may have been ameliorated by the addition of a low concentration of propofol.
Ketofol infusion might be especially useful for supplementing inadequate regional anaesthesia (as in case 4), due to its added analgesic property. It might also provide useful sedation and analgesia in highrisk patients requiring other procedures such as burn dressing changes and abscess drainage. Ketamine provides an analgesic component without significant respiratory depression. This is integral to its success. Ketofol infusion should be at least as suited to the task as midazolam/propofol sedation.
In conclusion, we have reported the successful use of ketofol infusion in conjunction with regional anaesthesia in four high-risk patients. Ketofol infusion demonstrated a number of benefits including airway preservation, maintenance of spontaneous respiration, haemodynamic stability, an analgesic effect and rapid recovery. 
